Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-09-22T11:55:58.153Z.
Calculation as of: 2026-09-22T11:55:58.153Z.
Quote observation: 2026-09-21T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c3ee83f44a2efdd70b4cb60cd726217b4474c91f0f3ed8ed7c47805bb1a8d1c9
EARNINGS YIELD
N/A
Market Cap
$47.08M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.02B
Earnings Yield
4.42%
TTM Avg
3.63%
3Y Avg
2.26%
5Y Avg
2.26%
Market Cap
$5.10B
Earnings Yield
2.83%
TTM Avg
2.77%
3Y Avg
2.37%
5Y Avg
2.03%
Market Cap
$5.77B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.14B | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $479.36M | 1.19% | 3.42% | 4.61% | 4.13% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.89B | N/A | 4.44% | 2.95% | 2.72% |
| Shoulder Innovations, Inc. (SI)vs › | $363.33M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $47.08M | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.02B | 4.42% | 3.63% | 2.26% | 2.26% |
| Doximity, Inc. (DOCS)vs › | $5.02B | 3.17% | 3.71% | 2.63% | 2.17% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 2.83% | 2.77% | 2.37% | 2.03% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.77B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.53B | 3.99% | 4.25% | 3.66% | 3.60% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
